Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah Eshagh

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Infection|June 28, 2020
Infliximab use for corticosteroid-resistant tuberculosis immune reconstitution inflammatory syndrome (TB-IRIS) in an immunocompetent patientDeborah Eshagh, Khadija Benali, Antoine Dossier, et al.
Journal of Translational Medicine|August 31, 2021
TFH cells in systemic sclerosisPauline Beurier, Laure Ricard, Deborah Eshagh, et al.
Plos One|December 17, 2020
Pre-test probability for SARS-Cov-2-related infection score: The PARIS scoreMickael Tordjman, Ahmed Mekki, Rahul D Mali, et al.
Stem Cell Reviews and Reports|January 6, 2021
Usefulness of Plasma SARS-CoV-2 RNA Quantification by Droplet-based Digital PCR to Monitor Treatment Against COVID-19 in a B-cell Lymphoma PatientTali-Anne Szwebel, David Veyer, Nicolas Robillard, et al.
Blood Cancer Journal|August 11, 2021
Weak immunogenicity of SARS-CoV-2 vaccine in patients with hematologic malignanciesFlorent Malard, Béatrice Gaugler, Joel Gozlan, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 26, 2025
ANCA-Associated Vasculitides in Systemic Sclerosis: A Unique Clinical Overlap with Significant Implications for Treatment and OutcomesDeborah Eshagh, Thomas Quéméneur, Alexandre Karras, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Infection|June 28, 2020
Infliximab use for corticosteroid-resistant tuberculosis immune reconstitution inflammatory syndrome (TB-IRIS) in an immunocompetent patientDeborah Eshagh, Khadija Benali, Antoine Dossier, et al.
Journal of Translational Medicine|August 31, 2021
TFH cells in systemic sclerosisPauline Beurier, Laure Ricard, Deborah Eshagh, et al.
Plos One|December 17, 2020
Pre-test probability for SARS-Cov-2-related infection score: The PARIS scoreMickael Tordjman, Ahmed Mekki, Rahul D Mali, et al.
Stem Cell Reviews and Reports|January 6, 2021
Usefulness of Plasma SARS-CoV-2 RNA Quantification by Droplet-based Digital PCR to Monitor Treatment Against COVID-19 in a B-cell Lymphoma PatientTali-Anne Szwebel, David Veyer, Nicolas Robillard, et al.
Blood Cancer Journal|August 11, 2021
Weak immunogenicity of SARS-CoV-2 vaccine in patients with hematologic malignanciesFlorent Malard, Béatrice Gaugler, Joel Gozlan, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 26, 2025
ANCA-Associated Vasculitides in Systemic Sclerosis: A Unique Clinical Overlap with Significant Implications for Treatment and OutcomesDeborah Eshagh, Thomas Quéméneur, Alexandre Karras, et al.
Pageof 1